BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22338918)

  • 1. Parathyroid hormone enhances osteoblast differentiation from human skin derived precursor cells in vitro.
    Suriyachand K; Bunyaratvej A; Bunyaratavej N; Sila-Asna M
    J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S1-6. PubMed ID: 22338918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
    Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
    J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential.
    Wang D; Christensen K; Chawla K; Xiao G; Krebsbach PH; Franceschi RT
    J Bone Miner Res; 1999 Jun; 14(6):893-903. PubMed ID: 10352097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation.
    Robinson JA; Susulic V; Liu YB; Taylor C; Hardenburg J; Gironda V; Zhao W; Kharode Y; McLarney S; Bai Y; Malone DP; Murrills R; Bex F
    J Cell Biochem; 2006 Aug; 98(5):1203-20. PubMed ID: 16514668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone [PTH(1-34)] and parathyroid hormone-related protein [PTHrP(1-34)] promote reversion of hypertrophic chondrocytes to a prehypertrophic proliferating phenotype and prevent terminal differentiation of osteoblast-like cells.
    Zerega B; Cermelli S; Bianco P; Cancedda R; Cancedda FD
    J Bone Miner Res; 1999 Aug; 14(8):1281-9. PubMed ID: 10457260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene.
    Onyia JE; Miles RR; Yang X; Halladay DL; Hale J; Glasebrook A; McClure D; Seno G; Churgay L; Chandrasekhar S; Martin TJ
    J Bone Miner Res; 2000 May; 15(5):863-71. PubMed ID: 10804015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.
    Merciris D; Marty C; Collet C; de Vernejoul MC; Geoffroy V
    Am J Pathol; 2007 May; 170(5):1676-85. PubMed ID: 17456773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP.
    Wang YH; Liu Y; Buhl K; Rowe DW
    J Bone Miner Res; 2005 Jan; 20(1):5-14. PubMed ID: 15619664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
    Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
    McCauley LK; Koh AJ; Beecher CA; Cui Y; Decker JD; Franceschi RT
    J Bone Miner Res; 1995 Aug; 10(8):1243-55. PubMed ID: 8585429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/PTHrP) receptor in bone development.
    Kondo H; Ohyama T; Ohya K; Kasugai S
    J Bone Miner Res; 1997 Dec; 12(12):2089-97. PubMed ID: 9421242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.
    Viereck V; Siggelkow H; Tauber S; Raddatz D; Schutze N; Hüfner M
    J Cell Biochem; 2002; 86(2):348-56. PubMed ID: 12112004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells.
    Shinoda Y; Kawaguchi H; Higashikawa A; Hirata M; Miura T; Saito T; Nakamura K; Chung UI; Ogata N
    J Cell Biochem; 2010 Mar; 109(4):755-63. PubMed ID: 20058231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
    Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
    J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages.
    Isogai Y; Akatsu T; Ishizuya T; Yamaguchi A; Hori M; Takahashi N; Suda T
    J Bone Miner Res; 1996 Oct; 11(10):1384-93. PubMed ID: 8889836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.